Prevalence of AR-positive cases was lower in high grade tumors (Figure 4A, p<0.01), but was consistently distributed among the different tumor stages (Figure 4A); 98.4% (300/305) of AR positive cases (98.6% in non-TNBC and 97.8% in TNBC) showed ≥10% AR expression. The gene discussed is AR; the disease is neoplasm.